Cargando…
Anti-BRAF/anti-MEK targeted therapies for metastatic melanoma patients during the COVID-19 outbreak: experience from an Italian skin cancer unit
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Future Medicine Ltd
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7874884/ https://www.ncbi.nlm.nih.gov/pubmed/33533662 http://dx.doi.org/10.2217/fon-2020-0997 |
| _version_ | 1783649679109521408 |
|---|---|
| author | Quaglino, Pietro Fava, Paolo Brizio, Matteo Marra, Elena Rubatto, Marco Merli, Martina Tonella, Luca Ribero, Simone Fierro, Maria Teresa |
| author_facet | Quaglino, Pietro Fava, Paolo Brizio, Matteo Marra, Elena Rubatto, Marco Merli, Martina Tonella, Luca Ribero, Simone Fierro, Maria Teresa |
| author_sort | Quaglino, Pietro |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7874884 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Future Medicine Ltd |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-78748842021-02-10 Anti-BRAF/anti-MEK targeted therapies for metastatic melanoma patients during the COVID-19 outbreak: experience from an Italian skin cancer unit Quaglino, Pietro Fava, Paolo Brizio, Matteo Marra, Elena Rubatto, Marco Merli, Martina Tonella, Luca Ribero, Simone Fierro, Maria Teresa Future Oncol Commentary Future Medicine Ltd 2021-02-03 2020-10 /pmc/articles/PMC7874884/ /pubmed/33533662 http://dx.doi.org/10.2217/fon-2020-0997 Text en © 2021 Future Medicine Ltd This work is licensed under the Creative Commons Attribution 4.0 License (http://creativecommons.org/licenses/by/4.0/) |
| spellingShingle | Commentary Quaglino, Pietro Fava, Paolo Brizio, Matteo Marra, Elena Rubatto, Marco Merli, Martina Tonella, Luca Ribero, Simone Fierro, Maria Teresa Anti-BRAF/anti-MEK targeted therapies for metastatic melanoma patients during the COVID-19 outbreak: experience from an Italian skin cancer unit |
| title | Anti-BRAF/anti-MEK targeted therapies for metastatic melanoma patients during the COVID-19 outbreak: experience from an Italian skin cancer unit |
| title_full | Anti-BRAF/anti-MEK targeted therapies for metastatic melanoma patients during the COVID-19 outbreak: experience from an Italian skin cancer unit |
| title_fullStr | Anti-BRAF/anti-MEK targeted therapies for metastatic melanoma patients during the COVID-19 outbreak: experience from an Italian skin cancer unit |
| title_full_unstemmed | Anti-BRAF/anti-MEK targeted therapies for metastatic melanoma patients during the COVID-19 outbreak: experience from an Italian skin cancer unit |
| title_short | Anti-BRAF/anti-MEK targeted therapies for metastatic melanoma patients during the COVID-19 outbreak: experience from an Italian skin cancer unit |
| title_sort | anti-braf/anti-mek targeted therapies for metastatic melanoma patients during the covid-19 outbreak: experience from an italian skin cancer unit |
| topic | Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7874884/ https://www.ncbi.nlm.nih.gov/pubmed/33533662 http://dx.doi.org/10.2217/fon-2020-0997 |
| work_keys_str_mv | AT quaglinopietro antibrafantimektargetedtherapiesformetastaticmelanomapatientsduringthecovid19outbreakexperiencefromanitalianskincancerunit AT favapaolo antibrafantimektargetedtherapiesformetastaticmelanomapatientsduringthecovid19outbreakexperiencefromanitalianskincancerunit AT briziomatteo antibrafantimektargetedtherapiesformetastaticmelanomapatientsduringthecovid19outbreakexperiencefromanitalianskincancerunit AT marraelena antibrafantimektargetedtherapiesformetastaticmelanomapatientsduringthecovid19outbreakexperiencefromanitalianskincancerunit AT rubattomarco antibrafantimektargetedtherapiesformetastaticmelanomapatientsduringthecovid19outbreakexperiencefromanitalianskincancerunit AT merlimartina antibrafantimektargetedtherapiesformetastaticmelanomapatientsduringthecovid19outbreakexperiencefromanitalianskincancerunit AT tonellaluca antibrafantimektargetedtherapiesformetastaticmelanomapatientsduringthecovid19outbreakexperiencefromanitalianskincancerunit AT riberosimone antibrafantimektargetedtherapiesformetastaticmelanomapatientsduringthecovid19outbreakexperiencefromanitalianskincancerunit AT fierromariateresa antibrafantimektargetedtherapiesformetastaticmelanomapatientsduringthecovid19outbreakexperiencefromanitalianskincancerunit |